logo
Plus   Neg
Share
Email

Starboard Value Urges All Shareholders To Reject Bristol-Myers - Celgene Merger

Starboard Value LP, a stockholder of Bristol-Myers Squibb Co. (BMY), said Tuesday it has issued an investor presentation opposing Bristol-Myers' proposed merger with Celgene Corp. (CELG), which it believes is ill-advised and not in the best interests of Bristol-Myers shareholders. It urges all shareholders to reject the proposed transaction.

New York-based investment adviser Starboard also announced that it has mailed definitive proxy materials and a BLUE proxy card for shareholders to vote against the proposed transaction at the upcoming special meeting of shareholders scheduled to take place on April 12, 2019.

In January 2019, Bristol-Myers Squibb said it would acquire Celgene in a cash and stock transaction with an equity value of approximately $74 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Justin Sun, the entrepreneur who founded the cryptocurrency platform TRON, has postponed his charity lunch with billionaire investor Warren Buffett due to ill health. "TRON Foundation announces postponement of Warren Buffett lunch, press conferences after founder Justin Sun falls ill with kidney stones.... Mountain Rose Herbs has recalled one lot of Fennel Seed Whole after the company found salmonella in part of its inventory. The Eugene, Oregon-based company has recalled all sizes ranging from 4 oz. to 50 lbs. of its Fennel Seed Whole, Lot #25031, because they have the potential to be contaminated... The U.S. Food and Drug Administration announced the suspension of the food facility registration of seafood producer Topway Enterprises Inc., also doing business as Kazy's Gourmet, following repeated food safety violations. From now, Topway will not be able to sell or distribute any food products.
Follow RTT